This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • OSCAR ENDO One Stop Assessment of Risk for Endomet...
Clinical trial

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Read time: 1 mins
Last updated:9th Oct 2013
It is to be achieved that in postmenopausal women through the combination of Hysteroscopy and intraoperative rapid section a positive predictiv value (PPV) regarding the objective illness like endometrial cancer or adenomatous hyperplasia of 100% so as a negativ predictiv value (NPV) of 99%.
Category Value
Study start date 2013-10-09

View full details